Wilson Sonsini Goodrich & Rosati

Wilson Sonsini Goodrich & Rosati is a leading international law firm founded in Silicon Valley with over 60 years of experience representing technology and life sciences companies. The firm has been involved with virtually every milestone innovation in Silicon Valley's evolution and has developed deep expertise in the life sciences sector, representing biotechnology, pharmaceutical, and medical device companies throughout their business lifecycle.

The firm provides comprehensive legal services including venture financing, public offerings, licensing agreements, M&A transactions, intellectual property strategy, and regulatory compliance. Their life sciences practice is particularly robust, with specialized teams handling everything from early-stage biotech financings to complex pharmaceutical licensing deals and medical device patent portfolios. The firm publishes a regular Life Sciences Report and hosts industry events including biotech summits and venture capital forums.

Recent notable transactions include advising ALX Oncology on a $150 million public offering, vTv Therapeutics on a global licensing agreement expansion, and Think Bioscience on patent matters for a $55 million Series A. The firm also secured a jury trial victory for Google in an advertising technology case, demonstrating litigation capabilities alongside transactional expertise.

Choose Wilson Sonsini when your life sciences company requires sophisticated legal counsel that can scale with your growth from Series A through IPO and beyond. The firm excels at handling complex, multi-faceted transactions where regulatory, IP, and corporate issues intersect, and where having a single firm coordinate across multiple legal disciplines provides strategic advantage.

Expect white-glove service with deep industry knowledge and access to extensive networks in the venture capital and life sciences investment community. The firm is particularly valuable when seeking counsel that understands both the scientific and business aspects of drug development, medical devices, or diagnostic technologies.

Wilson Sonsini maintains a dedicated life sciences practice serving biotechnology, pharmaceutical, and medical device companies across all stages of development. The firm's healthcare work spans venture financings for early-stage biotech companies, public offerings for clinical-stage drug developers, licensing agreements for pharmaceutical products, patent portfolio management for medical innovations, and M&A transactions in the life sciences sector.

The firm demonstrates healthcare commitment through its monthly Life Sciences Report publication, specialized biotech summits, and dedicated IP libraries for in-house counsel. Recent healthcare transactions include multiple public offerings, licensing agreements, and Series A financings for companies developing novel therapeutics, energy storage for medical applications, and biotechnology platforms.

The ideal client is a venture-backed life sciences company with significant growth ambitions, whether an early-stage biotech with promising clinical data seeking Series B+ financing, a clinical-stage pharmaceutical company preparing for partnership or licensing deals, or a medical device manufacturer approaching commercialization or public markets. Companies benefit most when they need integrated legal services across multiple domains and value long-term strategic counsel alongside transactional execution.